На главную
Результаты поиска “Coumadin for atrial fibrillation”
Anticoagulation strategies for Atrial Fibrillation [UndergroundMed]
For more videos, check out our website at: http://videos.undergroundmed.net
Просмотров: 2222 UndergroudMed
New Anticoagulants for Stroke Prevention in Atrial Fibrillation | Christian Ruff, MD
"New Anticoagulants for Stroke Prevention in Atrial Fibrillation" Christian Ruff, MD Treatment Options for Atrial Fibrillation and VTE March 4th, 2013 Brigham and Women's Hospital Boston, MA
Просмотров: 10547 NAThrombosisForum
Atrial Fibrillation, Coumadin®, & the CHADS2 Score--StopAfib.org interviews Dr. Manish Shah
http://www.stopafib.org If you have atrial fibrillation, how do you know your risk of stroke and whether or not you should be taking Coumadin® or warfarin? Dr. Manish Shah talks about the CHADS2 scoring system that addresses this afib controversy and how your doctor will assess your CHADS2 score. Dr. Shah is an electrophysiologist, Associate Director of Cardiac Arrhythmia Research at the Washington Hospital Center in Washington, D.C., and Assistant Professor of Medicine at Georgetown University School of Medicine. StopAfib.org, at http://www.StopAfib.org, is for atrial fibrillation patients by afib patients. A full video transcript can be found at: http://stopafib.org/newsitem.cfm/NEWSID/135
Просмотров: 5713 StopAfib
Warfarin, Diet and Atrial Fibrillation
James Edgerton, MD discusses diet changes and warfarin with an atrial fibrillation patient. Learn more about AFib patient education at MyAFibExperience.org
Просмотров: 242 American Heart Association
Natural 'Blood thinners' for Afib
This video is about Natural 'Blood thinners' for Afib. In this video, i talk about some natural blood thinners like Garlic, Ginger, Nattokwinase, Hawthorn, Motherwort etc and why i would not recommend them as an alternative to warfarin or the NOACs in patients with Afib
Просмотров: 22642 York Cardiology
Heart&Stroke Clinical Update www.heartandstroke.ca/clinicalupdate Hilton Toronto, December 2016 MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION Presented by: Peter Leong-Sit MD, MSc, FRCPC, FHRS (see below) Learning Objectives: 1.To review management strategies for atrial fibrillation 2.To identify good candidates for rhythm control or ablation for atrial fibrillation 3.To provide an overview of atrial fibrillation ablation principles 4.To provide an overview of invasive options for stroke prevention Peter Leong-Sit MD, MSc, FRCPC, FHRS Associate Professor Western University Cardiologist London Heart Rhythm Program The following video was provided with the permission of the speaker. The information is intended for the use of healthcare professionals for reference and education only and is not intended to be a substitute for healthcare professional advice, diagnosis or treatment. You should consult your healthcare professional for personal health matters.
Просмотров: 220 Heart and Stroke
Perioperative Management of Anticoagulation: 2016 CCS Atrial Fibrillation Guidelines
Perioperative Management of Anticoagulation in Patients with AF 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Featuring: L. Brent Mitchell, MD Libin Cardiovascular Institute of Alberta University of Calgary, and Alberta Health Services
Просмотров: 1820 Canadian Cardiovascular Society
9 atrial fibrillation Anticoagulation
Просмотров: 1244 drsarmaji
Atrial Fibrillation: Coumadin to Prevent Stroke
One of the potential devastating consequences of atrial fibrillation is a stroke. You can prevent a stroke with the use of a blood thinner called coumadin. HeartSmartMD co-founder, author and board certified cardiologist Dr. Matt DeVane explains the risks and benefits of using coumadin to prevent strokes in atrial fibrillation. Learn much more at www.HeartSmartMD.com
Просмотров: 641 HeartSmartMD
Goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
Description of goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
Просмотров: 690 Diego Belardi
Warfarin Anticoagulation, Dementia, and Atrial Fibrillation
DescriptioDr. Malini Madhavan, an Assistant Professor of Cardiology at Mayo Clinic in Rochester, MN, discusses her article appearing in the February 2018 issue of Mayo Clinic Proceedings which examined the effect of anticoagulation in patients experiencing atrial fibrillation and its relationship to dementia. She found significant reductions in the incidence of dementia in those patients maintaining therapeutic levels of warfarin. She notes further studies are needed for the effects of newer anticoagulants. Available at: https://tinyurl.com/ycjvxykkn
Просмотров: 42 Mayo Proceedings
Bridging Anticoagulation
ISTH 2015 - Thomas Ortel, Chief, Division of Hematology, Professor of Medicine and Hematology and Medical Director, Clinical Coagulation Laboratory, Duke University Medical Center - The management of patients with atrial fibrillation on warfarin who need treatment interruption for surgery/procedure is a common clinical problem. Bridging with low-molecular-weight heparin has been used to minimize the time that patients are not anticoagulated to mitigate the risk for arterial thromboembolism. This study seeks to determine the efficacy and safety of bridging anticoagulation.
Просмотров: 2559 Thrombosis.TV
Coumadin (Warfarin): Clinical Pharmacist Explains Everything You Should Know
Dr. Jacqueline DiMarco, clinical pharmacist, explains everything patients should know about the blood thinner Coumadin (warfarin). We cover the mechanism of action against vitamin K, the conditions it treats (including atrial fibrillation and deep vein thrombosis a.k.a DVT), the INR and how it should be monitored, as well as the Lovenox bridge and dietary recommendations. Make sure to check us out on the web at http://www.DoctorVoices.com for the most dependable health information on the internet. This video and all content produced by Doctor Voices is for educational purposes only, please make sure to follow with your doctor for all of your health conditions. Please see our terms of use on our site.
Просмотров: 31127 Doctor Voices
How does warfarin help if I have atrial fibrillation?
Specialist Dr John Worthington talks about the anticoagulant medicine warfarin, including how it reduces the risk of stroke in people with atrial fibrillation. Find out more about warfarin at http://www.nps.org.au/warfarin
Просмотров: 670 NPS MedicineWise
Atrial Fibrillation & Coumadin® Replacements--StopAfib.org interviews Dr. Manish Shah
http://www.stopafib.org Dr. Manish Shah talks about Dabigatran and Rivaroxaban, new drugs in clinicals trials to replace the blood thinner Coumadin® (warfarin), an anticoagulant frequently used to avoid strokes by those with atrial fibrillation. He talks about the two categories of these new drugs, thrombin inhibitors and Factor Xa (10a) inhibitors. Dr. Shah is Associate Director of Cardiac Arrhythmia Research at the Washington Hospital Center in Washington, D.C., and Assistant Professor of Medicine at Georgetown University School of Medicine. StopAfib.org, at http://www.StopAfib.org, is for atrial fibrillation patients by afib patients. A full video transcript can be found at: http://stopafib.org/newsitem.cfm/NEWSID/135
Просмотров: 4886 StopAfib
Anticoagulants in atrial fibrillation
Everything you need to know about taking anticoagulants in atrial fibrillation (AF).
Просмотров: 690 Guy's and St Thomas' NHS Foundation Trust
Anticoagulation and risk of bleeding with Atrial Fibrillation
Eric Prystowsky, MD explains important points to keep in mind when weighing the risk of stroke and bleeding risk with anticoagulation for AFib patients.
Просмотров: 101 American Heart Association
Familial Afib, Peri-procedural Anticoagulation and CKD
Familial Afib, Peri-procedural Anticoagulation and CKD
Просмотров: 129 American College of Cardiology
Atrial fibrillation -- achieving safer anticoagulation
Sunil Rao John Alexander
Просмотров: 137 Duke Clinical Research Institute
Comparing Eliquis to Warfarin In Atrial Fibrillation Patients
While warfarin has long been a common treatment option for patients with atrial fibrillation new medications are coming to the market which provide different benefits than the original option.
Просмотров: 3226 MD Magazine
What are my options for anticoagulation therapy for Atrial Fibrillation?
Mintu Turakhia, MD, MAS, discusses the difference in oral anticoagulants and anticoagulation therapy that includes a clinic or coach. To connect with other patients visit: http://spr.ly/60598YnMv
Просмотров: 119 American Heart Association
Eliquis: New Medication for Atrial Fibrillation
An in-depth conversation between Pentucket Medical cardiologists Seth Bilazarian and Sunny Srivastava, focusing on a newly released medicine to reduce the risks of atrial fibrillation. The latest among recently approved blood thinners, Eliquis joins Pradaxa and Xarelto as an alternative to Coumadin, a drug that has been in use since the 1950s. Like Pradaxa and Xarelto, Eliquis has been shown to reduce risk of stroke and bleeding, as well as mortality. All the new drugs eliminate the need for regular blood testing that Coumadin necessitates.
Просмотров: 27421 PentucketMedical
Atrial Fibrillation Patients Are at Increased Risk of Dementia, Regardless of Anticoagulation Use
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions. Researcher and electrophysiologist Jared Bunch, MD, with the Intermountain Medical Center Heart Institute, explains the study, which was presented at the American Heart Association Scientific Sessions in New Orleans.
Просмотров: 71 Healthy Dialogues
Atrial Fibrillation in Older Adults: Anticoagulation
November 18th, 2016 Michael A. Chen, MD, PhD Associate Professor of Medicine Division of Cardiology Harborview Medical Center University of Washington
Просмотров: 102 NW GWEC
The BRIDGE Trial
Patients with atrial fibrillation are at increased risk of stroke. Warfarin anticoagulation is often used to reduce risk, but it is usually stopped perioperatively. Temporary “bridging” with heparin is common, but is it necessary? New research findings are summarized in a short video. See the NEJM article: "Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation": http://www.nejm.org/doi/full/10.1056/NEJMoa1501035
Просмотров: 3614 NEJMvideo
Exercise "Dose" and Anticoagulation for AFib
Dr. Christopher Cannon discusses articles appearing this week in Circulation, AJC, and in NEJM on exercise "dose" and on anticoagulation for Afib. Christopher P. Cannon, MD, FACC Statements or opinions expressed in this program reflects the views of the contributors and do not reflect the official policy of the ACCF, unless otherwise noted.
Просмотров: 641 American College of Cardiology
AFib: Anticoagulation Strategies - Dallas CVI 2015
Dr. Owen Obel discusses new treatments for atrial fibrillation
Просмотров: 410 Manos Brilakis
What do I need to know about Warfarin?
Join our channel by subscribing here. If you have enjoyed our video, please like it and leave a comment about what other videos you may be interested in. Your help in creating great, relevant content is greatly appreciated. Discover everything patients should know about the blood thinner Coumadin (Warfarin). I cover the mechanism of action against vitamin K, the conditions it treats (including atrial fibrillation and deep vein thrombosis a.k.a DVT), the INR and how it should be monitored. This video describes the role of Warfarin in managing atrial fibrillation. Also included are modern day pros and cons of still using this medication that has been available for well over 50 years. Transcript: Thank you for visiting doctor AFib, I'm Dr. Morales. In today's video segment we're going to be talking about a blood thinner that has been on the market for well over 50 years, known as Warfarin or also goes by the brand name of Coumadin.Yes, it was first advertised and marketed as a rat poison way back in the 1940s. But starting in the 1950s it began to be approved for human use as a blood thinner.Nowadays it's actually used for several purposes, including for reducing the risk of stroke for atrial fibrillation, but also for treating deep venous thrombosis, pulmonary embolism as well as an anticoagulant for mechanical heart valves. Starting in the late 1980s and into the 1990s there were several clinical trials comparing Warfarin with aspirin for reducing the risk of stroke for atrial fibrillation.Several times Warfarin was shown to be superior for reducing the risk of stroke.In meta-analysis where they combined data from several clinical trials, it showed that Warfarin reduces the risk of stroke by about 66 percent. However, there are a lot of nuances when it comes to managing somebody who has taken Warfarin. First of all, not everybody's dose is the same based on how individuals metabolize the medication. There's a blood test called an INR, which helps your doctor monitor your Warfarin level to find the right dosage for you.At the beginning, very frequently people will have the blood tested every week until you find the correct dosage for you.After that stage, it may be only checked about once a month The target level on the blood test for most people is between a level between two to three in that INR blood test. However, there's been several studies that have shown that the amount of time people are actually within that recommended range can range anywhere from 50 to 70 percent of the time which shows that at least 30% of the time or even more patients are not within the recommended range of that INR level. Listen to the video for more Read my blog posts at http://www.DrAFib.com
Просмотров: 302 Dr. AFib
6/16/17: Atrial Fibrillation: Can We Organize the Chaos?
Anne O'Connor, MD and Jennifer Wright, MD co-present a lecture about clinical management of atrial fibrillation. Dr. O'Connor is an Associate Professor (CHS) whose clinical interests include critical cardiology, reducing readmissions for heart failure and acute myocardial infarct patients, and cardiovascular imaging. Dr. Wright is a Clinical Assistant Professor who specializes in cardiology and electrophysiology. Both are members of the Division of Cardiovascular Medicine in the Department of Medicine at UW-Madison. The title of their June 16, 2017 Grand Rounds talk is "Atrial Fibrillation: Can We Organize the Chaos?" University of Wisconsin Department of Medicine Grand Rounds are presented throughout the academic year and are intended for health care professionals and medical researchers. Unless otherwise indicated, Grand Rounds occurs in the William S. Middleton Memorial Veterans Hospital auditorium, Room A1028, Madison, Wisconsin. All faculty and staff are invited and encouraged to attend. For more information on the Grand Rounds lecture series, visit http://www.medicine.wisc.edu/dom/medicine-grand-rounds
Просмотров: 2187 UW Department of Medicine
Top Developments in Anticoagulant - Anticoagulation in AF  (Heart&Stroke Clinical Update)
Heart & Stroke Clinical Update 2015 www.heartandstroke.ca/clinicalupdate Plenary 3c Top Developments in Anticoagulant - Oral Anticoagulation for AF-related Stroke Prevention Presented by: Andrew Ha, MD, FRCPC (see below) Hilton Toronto, December 2015 Learning Objectives 1. Review common stroke and bleeding assessment schema for patients with atrial fibrillation (AF). 2. Review randomozed controlled trials comparing the efficacy and safety of warfarin versus noval oral anticoagulants (NOAC). 3. Discussion of “real-world” observational studies on the use of warfarin and NOAC agents. 4. Review the safety and effectiveness of oral anticoagulation in high-risk patient subgroups (e.g. chronic kidney disease). 5. Reversal agents for NOACs Session Description Stroke prevention with oral anticoagulation (OAC) is one of the most important treatment goals in the management of patients with atrial fibrillation (AF). Traditionally, warfarin is the drug of choice for AF-related stroke prevention. Recently, the introduction of novel oral anticoagulant (NOAC) agents has revolutionized this field. As a consequence of the rapid uptake of NOAC agents in clinical practice, health practitioners now face many new questions when prescribing OAC for AF patients with elevated stroke risk. For instance, there is a pressing need to develop a greater understanding of the “real-world” effectiveness and safety between warfarin and NOAC agents. In addition, further delineation of the risks and benefits of warfarin vs. NOAC agents in high-risk AF patient subgroups (e.g. elderly, patients with kidney disease, patients treated with antiplatelet therapy) will be most welcomed. In this session, we will examine data from randomized clinical trials, “real-world” registries, and large-scale health administrative databases to address these keys questions on OAC use for AF-related stroke prevention. Andrew Ha, MD, FRCPC Staff cardiac electrophysiologist, Toronto General Hospital, University Health Network The following information was provided by speakers at the Clinical Update 2015. The information is intended for use by healthcare professionals for reference and education only and is not intended to be a substitute for a physician's advice, diagnosis or treatment. You should consult your physician for personal health matters.
Просмотров: 1516 Heart and Stroke
Anticoagulants for Afib
Просмотров: 8099 Healthline
AFib, anticoagulants and antidotes
In this video, Dr Sanjay Gupta, discusses the role of different anticoagulants in atrial fibrillation and why the lack of antidotes shouls not put anyone off using the NOACS.
Просмотров: 1517 York Cardiology
Atrial Fibrillation & Anticoagulants--StopAfib.org interviews Dr. Elaine Hylek
http://www.stopafib.org StopAfib.org interviews Dr. Elaine Hylek of Boston University. A transcript of this video, as well as additional information about the topics discussed, and Dr. Hylek, can be found at: http://www.stopafib.org/newsitem.cfm/NEWSID/349 In this video interview, Dr. Elaine Hylek of Boston University discusses new anticoagulant drugs for stroke prevention in atrial fibrillation. For many years, warfarin (Coumadin) has been the only anticoagulant option for patients. Taking warfarin requires constant monitoring, and it can be a challenge for many patients. In addition to drug-drug interactions and food-drug interactions, warfarin can be affected by illness or heart failure. Dr. Hylek discusses the clinical trials results for two of the new anticoagulants that are alternatives to warfarin. Dr. Hylek is the Director of Thrombosis and Anticoagulation Services at the Boston Medical Center, and is an Associate Professor at of Medicine at Boston University.
Просмотров: 2362 StopAfib
AF patient wanted alternative to warfarin
© Arrhythmia Alliance 2015 Meet Leslie John Page. He got atrial fibrillation (AF) aged 66-years-old. He was prescribed warfarin, which did not suit his body or lifestyle. He was visiting the doctor on a weekly basis, had to limit his social life and felt poorly. He was advised to take the left atrial appendage procedure. Watch the video to find out what this procedure involves and how it transformed his life. This video has been produced by Watchman.
Просмотров: 3396 ArrhythmiaAlliance
Atrial Fibrillation Anticoagulation - PowerPoint Presentation
http://www.medicaldump.com - Please visit the site for FREE medical PowerPoints, medical PowerPoint templates, medical e-books related to all specialties including ophthalmology, cardiology, neurology, nephrology, GI, etc. This is a Cardiology PowerPoint presentation about Atrial Fibrillation Anticoagulation.
Просмотров: 658 medicaldump
Apixaban Versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with AF
This interview with Jens Cosedis Nielsen from Aarhus University Hospital, Aarhus, DK discusses Apixaban Versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with Atrial Fibrillation Scheduled for Cardioversion at ESC 2017.
Просмотров: 199 Radcliffe Group
Coumadin Monitoring At Home
In this episode of Matters Of The Heart, Pentucket Medical cardiologists Dr. Seth Bilazarian and Dr. Sunny Srivastava engage in a detailed discussion of new devices and medications that may benefit certain types of heart patients. Coumadin, or Warfarin, has been a life-saving medication for millions of patients at risk for stroke or atrial fibrillation. However, Coumadin comes with a burden, requiring regular blood tests so that levels can be kept within safe limits. In the past, monitoring has required regular trips to the doctors office. More recently, home testing devices have become available, and approved (and paid for) by Medicare. (Produced in March of 2011) Pentucket Medical Associates offers Cardiology care in the following locations: Haverhill, MA: (978) 521-3288 RiverWalk in Lawrence, MA: (978) 557-8900 Newburyport, MA: (978) 499-7400
Просмотров: 69 PentucketMedical
Atrial fibrillation and stroke - the professional perspective
Dr Matthew Fay (GP and AF specialist) and Brendan Young (Patient representative on West Midland Clinical Senate) speak about the importance of anticoagulation for stroke prevention in patients with AF
Просмотров: 777 Stroke Association
8 atrial fibrillation Management
Просмотров: 16886 drsarmaji
Treatment Guidelines for Atrial Fibrillation, AF Patients
Treatment Guidelines for Atrial Fibrillation, AF Patients: Current ESC Guidelines for patients with atrial fibrillation explicitly recommend an oral anticoagulant for patients with two additional risk factors. And in patients with one additional risk factor an oral anticoagulant is recommended in preference to aspirin. Yet only half of all patients who need an anticoagulant, as defined by guidelines, actually receive one. Not surprisingly, it turns out that only one in ten people with AF who suffer a stroke were receiving adequate anticoagulant protection at the time. References: Gladstone DJ, B ui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009;40(1):235-240. Waldo AL, Becker RC, Tapson VF, et al; NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005;46(9):1729-1736. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360-1420.
Просмотров: 16613 Thrombosis Adviser
NOACs should replace warfarin in all patients with atrial fibrillation - Pro - J. Camm
This video was recorded during the ESC Heart & Brain workshop course held at Charles University in Prague, Czech Republic. The goal of this first edition of this workshop was to bring together leading experts in the field of stroke and cardiologists, neurologists, radiologists, surgeons and other specialists to learn from each other. Find out more about the ESC Council on Stroke: https://www.escardio.org/Councils/Council-on-Stroke?hit=youtube
Просмотров: 152 European Society of Cardiology
Atrial Fibrillation (AF or AFib)
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Some people refer to AF as a quivering heart. An estimated 2.7 million Americans are living with AF.
Просмотров: 22391 American Heart Association
Atrial Fibrillation Drugs and Trials--StopAfib.org interviews Dr. Peter Kowey
http://www.stopafib.org StopAfib.org interviews Dr. Peter Kowey See the full transcript at: http://www.stopafib.org/newsitem.cfm/NEWSID/255 In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Peter Kowey talked about a number of exciting new things in the atrial fibrillation world, including the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a replacement for amiodarone, atrial selective drugs, and coming replacements for Coumadin (warfarin).
Просмотров: 1289 StopAfib
Weighing Your Options – Anticoagulation Therapy
Watch this short video to learn more about the benefits and risks of anticoagulants, a common medication for those diagnosed with AFib.
Просмотров: 1720 National Stroke Association
Borealis AF Study: Atrial Fibrillation Clinical Trial 1 - livingwithafib.com
What is the Borealis AF research study for people with Afib? The Borealis AF study is specifically for people with Afib. It is being conducted to determine if the investigational study drug is safe and as effective as warfarin (Coumadin®) in reducing the risk of stroke. The Borealis AF study is researching an investigational medication to see if it can help to prevent a stroke. This investigational medication (given once weekly) may serve as an alternative to standard daily blood thinning medications for people in the future. Can I take part in the Borealis AF study? The Borealis AF study is for people diagnosed with Afib. Click here to complete a brief questionnaire and determine if you pre-qualify for the Borealis AF study. Go to www.livingwithafib.com. By completing this questionnaire you are under no obligation to take part in this research study.
Просмотров: 115 acuriantrials
Catheter Ablation of Atrial Fibrillation
Dr. Kneller discusses comprehensive management strategy for atrial fibrillation, including anticoagulation, anti-arrhythmic drug therapy, continuous monitoring of atrial fibrillation with the Medtronic Reveal LINQ, and strategies for catheter ablation of atrial fibrillation including optimal use of the CARTO V3 mapping system.
Просмотров: 3341 JamesKnellerMD
Atrial Fibrillation: Symptoms Treatment Medications
Dr. Alo discusses atrial fibrillation treatment algorithms including many of the newer rate and rhythm control drugs. Also discusses the novel anticoagulation options. Target audience is informed patients and medical professionals. hhtp://MohammedAlo.com
Просмотров: 10520 Mohammed Alo
Atrial fibrillation: 2 key managment issues explained
In this video we try to explain two of the key issues for the management of atrial fibrillation. 1.The first issue is the issue of heart rate control versus heart rhythm control. Will your physician try to just control your heart rate or try to flip your rhythm back in to sinus rhythm from atrial fibrillation? With heart rate control our goal is to try to control the heart rate only. Thus the patient could still be in atrial fibrillation however heart rate is brought under control (60-110 bpm) with medications like beta blockers- metoprolol and calcium channel blockers like diltiazem etc. By rhythm control the physician tries to reset the heart into into sinus rhythm from atrial fibrillation. This can be done with the help of medications and is called as chemical cardioversion. Or it can be done by electrical shock also known as electrical cardioversion. Medications that can be used to keep the patient in the rhythm. These medications include, flecanide, sotalol or amiodarone etc. 2. The second key issue in the management of atrial fibrillation is prevention of stroke. Stroke is a deadly complication of atrial fibrillation. The first question that arises is what is the risk of stroke in a given patient with atrial fibrillation. A patients risk of stroke can be calculated by using an abbreviation called CHAD2VASC2 (explained in the table). Blood thinners (like Coumadin or newer agents like xeralto/apixaban/rivaroxaban) are recommended for patients with a score more than 2. For a score of zero usually no blood are recommended and for patients with the score of one either blood thinner or are aspirin as recommended. If you like this video and would like to see more of such patient educational videos go to our website www.patienteducationpro.com.
Просмотров: 1533 PatientEducationPro